Vertex Pharma (VRTX) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $548.05 +1.44%
Financial Fact:
Provision for income taxes (Alios): 503K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Provision for income taxes (Alios): 503K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) reported Q3 EPS of ($0.39), $0.09 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $309.8 million versus the consensus estimate of $245.84 million.
For earnings history and earnings-related data on Vertex Pharma (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
